Friday, 26 May 2017

Singapore News

  • A*Star peptides help understand Alzheimer's, cancer

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A new class of ultrasmall peptides developed by A*Star's Institute of Bioengineering and Nanotechnology (IBN) is providing scientists a platform for understanding degenerative di...Read more

  • Mundipharma buys Merck's ophthalmology business

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Mundipharma Ophthalmology Products has announced an agreement with MSD, known as Merck in the United States and Canada, to acquire MSD's ophthalmology portfolio for the treatment...Read more

  • IBM, A*Star co-develop anti-microbial hydrogel

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial hydrogel that can break apart biofilms and destroy ...Read more

  • Pfizer launches targeted therapy for lung cancer in Singapore

    Singapore |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singapore. Xalkori is used to treat patients with late-stage (locally adv...Read more

  • Singapore market forecast

    Singapore |  Opinion | By BioSpectrum Bureau | 0 Comment

    Singapore: Over the past 15 years, Singapore has developed into a renowned bioscience cluster through top-down investment in world-class infrastructure and skilled talent for R&D and bi...Read more

  • HSA nod for Aslan rheumatoid arthritis drug

    Singapore |  Regulatory | By BioSpectrum Bureau | 0 Comment

    Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Trial Certificate Application for ASLAN003, which is a novel oral small ...Read more

  • Covance recieves Frost and Sullivan Award

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Covance, a global drug development company, has recieved the 2014 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award, for its business performance and conti...Read more

  • Challenge No 5: Talent trouble

    Singapore |  Analysis | By Narayan Kulkarni | 0 Comment

    Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially for conducting R&...Read more

  • BI shows afatinib to be effective in advanced squamous cell carcinoma of lung

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in patients with advanced squamous cell carcinoma (SCC) of the lung. The...Read more

  • BMS reacquires rights to oncology drug from Asia Partner

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ASLAN Pharmaceuticals (ASLAN), a biotech company focused on the development of immunotherapies and targeted agents for Asia-prevalent tumour types, today announced that Bristol-M...Read more

  • ICON appoints APAC and Japan VPs

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has appointed Ms Mary Pan as vice president...Read more

  • Personalized medicine market to reach $149 bn by 2020

    Singapore |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: Personalized medicine market will be worth over USD149 billion by 2020, growing at a CAGR of 8.74 percent, and will be driven by oncology, cardiovascular and infectious disease t...Read more

  • Singapore cancer genome scientists win President's Science Award

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome Institute of Singapore (GIS), Professor Teh Bin Tean from the Nationa...Read more

  • A*STAR co-develops diagnostic tool for brain injury

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A*STAR's Institute of Microelectronics (IME) and SFC Fluidics, a US-based microfluidics and biomedical device development company, will be collaborating to develop a portable dia...Read more

  • How to get your drug registered in Singapore?

    Singapore |  Regulatory | By Amrita Tejasvi | 0 Comment

    The sector of life sciences in the Asia Pacific (APAC) region offers massive opportunities for companies, which are looking for growth. These firms often face many regulatory challenges in ...Read more

  • Progress in optical imaging creating opportunities

    Singapore |  Analysis | By BioSpectrum Bureau | 0 Comment

    Singapore: Current optical imaging technologies provide reproducible, accurate, objective, quantitative assessments of tissue structures. As the marked progress in optical imaging technique...Read more

  • Future of Customer Experience for the Pharmaceutical Players

    Singapore |  Opinion | By BioSpectrum Bureau | 0 Comment

    Singapore: Consumers have a habit of reshaping industries at inconvenient and unexpected times. Their expectations and demands may initially appear irrational, or impossible. But over time,...Read more

  • Singaporeans depend on Chinese medicine to treat arthritis

    Singapore |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: A local survey of elderly Singaporeans found 42 percent of the respondents to have knee pain with 40.7 percent living in pain for five years or more. The survey revealed that onl...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls